{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:27:07Z","timestamp":1774121227754,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"36","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Altered expression of Urea Cycle (UC) enzymes occurs in many tumors, resulting a metabolic hallmark termed as UC dysregulation. Polyamines are synthesized from ornithine, and polyamine synthetic genes are elevated in various tumors. However, the underlying deregulations of UC\/ polyamine synthesis in cancer remain elusive. Here, we characterized a hypoxia-induced lncRNA LVBU (lncRNA regulation via BCL6\/urea cycle) that is highly expressed in colorectal cancer (CRC) and correlates with poor cancer prognosis. Increased LVBU expression promoted CRC cells proliferation, foci formation and tumorigenesis. Further, LVBU regulates urea cycle and polyamine synthesis through BCL6, a negative regulator of p53. Mechanistically, overexpression of LVBU competitively bound miR-10a\/miR-34c to protect BCL6 from miR-10a\/34c-mediated degradation, which in turn allows BCL6 to block p53-mediated suppression of genes (arginase1 <jats:italic>ARG1<\/jats:italic>, ornithine transcarbamylase <jats:italic>OTC<\/jats:italic>, ornithine decarboxylase 1 <jats:italic>ODC1<\/jats:italic>) involved in UC\/polyamine synthesis. Significantly, ODC1 inhibitor attenuated the growth of patient derived xenografts (PDX) that sustain high LVBU levels. Taken together, elevated LVBU can regulate BCL6-p53 signaling axis for systemic UC\/polyamine synthesis reprogramming and confers a predilection toward CRC development. Our data demonstrates that further drug development and clinical evaluation of inhibiting UC\/polyamine synthesis are warranted for CRC patients with high expression of LVBU.<\/jats:p>","DOI":"10.1038\/s41388-022-02413-8","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:04:04Z","timestamp":1659078244000},"page":"4231-4243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Roles of lncRNA LVBU in regulating urea cycle\/polyamine synthesis axis to promote colorectal carcinoma progression"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-6122","authenticated-orcid":false,"given":"Xiangqi","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-292X","authenticated-orcid":false,"given":"Lekun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-8215","authenticated-orcid":false,"given":"Mong-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"2413_CR1","first-page":"269","volume":"3","author":"JM Kocarnik","year":"2015","unstructured":"Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep. 2015;3:269\u201376.","journal-title":"Gastroenterol Rep."},{"key":"2413_CR2","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer J clinicians. 2019;69:7\u201334.","journal-title":"CA: a cancer J clinicians"},{"key":"2413_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-019-0241-1","volume":"17","author":"A Sveen","year":"2020","unstructured":"Sveen A, Kopetz S, Lothe RA. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol. 2020;17:11\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"2413_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/gox031","volume":"6","author":"S Zou","year":"2018","unstructured":"Zou S, Fang L, Lee MH. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep. 2018;6:1\u201312.","journal-title":"Gastroenterol Rep"},{"key":"2413_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-0247-6","volume":"6","author":"M Agostini","year":"2020","unstructured":"Agostini M, Ganini C, Candi E, Melino G. The role of noncoding RNAs in epithelial cancer. Cell death Discov. 2020;6:13.","journal-title":"Cell death Discov"},{"key":"2413_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/gutjnl-2019-318279","volume":"69","author":"MP Dragomir","year":"2020","unstructured":"Dragomir MP, Kopetz S, Ajani JA, Calin GA. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut. 2020;69:748\u201363.","journal-title":"Gut"},{"key":"2413_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15884","volume":"8","author":"F Lucien","year":"2017","unstructured":"Lucien F, Pelletier PP, Lavoie RR, Lacroix JM, Roy S, Parent JL, et al. Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance. Nat Commun. 2017;8:15884.","journal-title":"Nat Commun"},{"key":"2413_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","volume":"51","author":"V Bhandari","year":"2019","unstructured":"Bhandari V, Hoey C, Liu LY, Lalonde E, Ray J, Livingstone J, et al. Molecular landmarks of tumor hypoxia across cancer types. Nat Genet. 2019;51:308\u201318.","journal-title":"Nat Genet"},{"key":"2413_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","volume":"15","author":"FJ Gonzalez","year":"2018","unstructured":"Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol. 2018;15:21\u201332.","journal-title":"Nat Rev Endocrinol"},{"key":"2413_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-immunol-100819-121537","volume":"38","author":"SP Colgan","year":"2020","unstructured":"Colgan SP, Furuta GT, Taylor CT. Hypoxia and Innate Immunity: Keeping Up with the HIFsters. Annu Rev Immunol. 2020;38:341\u201363.","journal-title":"Annu Rev Immunol"},{"key":"2413_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"CT Taylor","year":"2017","unstructured":"Taylor CT, Colgan SP. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol. 2017;17:774\u201385.","journal-title":"Nat Rev Immunol"},{"key":"2413_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2413_CR13","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-018-0382-1","volume":"37","author":"SJ Deng","year":"2018","unstructured":"Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S, Zeng Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37:5811\u201328.","journal-title":"Oncogene"},{"key":"2413_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","volume":"64","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto S, H\u00e4berle J, Kido J, Mitsubuchi H, Endo F, Nakamura K. Urea cycle disorders-update. J Hum Genet. 2019;64:833\u201347.","journal-title":"J Hum Genet"},{"key":"2413_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","volume":"174","author":"JS Lee","year":"2018","unstructured":"Lee JS, Adler L, Karathia H, Carmel N, Rabinovich S, Auslander N, et al. Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures. Cell. 2018;174:1559\u20131570.","journal-title":"Cell"},{"key":"2413_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-019-0996-7","volume":"567","author":"L Li","year":"2019","unstructured":"Li L, Mao Y, Zhao L, Li L, Wu J, Zhao M, et al. p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis. Nature. 2019;567:253\u20136.","journal-title":"Nature"},{"key":"2413_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich S, Adler L, Yizhak K, Sarver A, Silberman A, Agron S, et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature. 2015;527:379\u201383.","journal-title":"Nature"},{"key":"2413_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","volume":"18","author":"R Keshet","year":"2018","unstructured":"Keshet R, Szlosarek P, Carracedo A, Erez A. Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer. 2018;18:634\u201345.","journal-title":"Nat Rev Cancer"},{"key":"2413_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-017-0014-1","volume":"1","author":"W He","year":"2017","unstructured":"He W, Roh E, Yao K, Liu K, Meng X, Liu F, et al. Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression. NPJ Precis Oncol. 2017;1:13.","journal-title":"NPJ Precis Oncol"},{"key":"2413_CR20","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1074\/jbc.TM118.003336","volume":"293","author":"AS Bachmann","year":"2018","unstructured":"Bachmann AS, Geerts D. Polyamine synthesis as a target of MYC oncogenes. J Biol Chem. 2018;293:18757\u201369.","journal-title":"J Biol Chem"},{"key":"2413_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1158\/1078-0432.CCR-16-2071","volume":"23","author":"MG Cardenas","year":"2017","unstructured":"Cardenas MG, Oswald E, Yu W, Xue F, MacKerell AD Jr., Melnick AM. The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target. Clin Cancer Res: Off J Am Assoc Cancer Res. 2017;23:885\u201393.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"2413_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14728222.2018.1420782","volume":"22","author":"RJ Leeman-Neill","year":"2018","unstructured":"Leeman-Neill RJ, Bhagat G. BCL6 as a therapeutic target for lymphoma. Expert Opin therapeutic targets. 2018;22:143\u201352.","journal-title":"Expert Opin therapeutic targets"},{"key":"2413_CR23","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1073\/pnas.1609758114","volume":"114","author":"L Xu","year":"2017","unstructured":"Xu L, Chen Y, Dutra-Clarke M, Mayakonda A, Hazawa M, Savinoff SE, et al. BCL6 promotes glioma and serves as a therapeutic target. Proc Natl Acad Sci. 2017;114:3981\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"2413_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","volume":"18","author":"RA Casero Jr","year":"2018","unstructured":"Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18:681\u201395.","journal-title":"Nat Rev Cancer"},{"key":"2413_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc.2016.140","volume":"17","author":"AT Byrne","year":"2017","unstructured":"Byrne AT, Alf\u00e9rez DG, Amant F, Annibali D, Arribas J, Biankin AV, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17:254\u201368.","journal-title":"Nat Rev Cancer"},{"key":"2413_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the Intersections between Metabolism and Cancer Biology. Cell. 2017;168:657\u201369.","journal-title":"Cell"},{"key":"2413_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","volume":"27","author":"J Miska","year":"2019","unstructured":"Miska J, Lee-Chang C, Rashidi A, Muroski ME, Chang AL, Lopez-Rosas A, et al. HIF-1alpha Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma. Cell Rep. 2019;27:226\u2013237.","journal-title":"Cell Rep"},{"key":"2413_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/blood.2021011010","volume":"139","author":"JA Willson","year":"2022","unstructured":"Willson JA, Arienti S, Sadiku P, Reyes L, Coelho P, Morrison T, et al. Neutrophil HIF-1alpha stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood. 2022;139:281\u20136.","journal-title":"Blood"},{"key":"2413_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3324\/haematol.2019.246330","volume":"105","author":"M Seiffert","year":"2020","unstructured":"Seiffert M. HIF-1\u03b1: a potential treatment target in chronic lymphocytic leukemia. Haematologica. 2020;105:856\u20138.","journal-title":"Haematologica"},{"key":"2413_CR30","first-page":"1635","volume":"42","author":"S Xiong","year":"2019","unstructured":"Xiong S, Hu M, Li C, Zhou X, Chen H. Role of miR\u201134 in gastric cancer: From bench to bedside (Review). Oncol Rep. 2019;42:1635\u201346.","journal-title":"Oncol Rep"},{"key":"2413_CR31","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/jca.33831","volume":"11","author":"H Welponer","year":"2020","unstructured":"Welponer H, Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, et al. The miR-34 family and its clinical significance in ovarian cancer. J Cancer. 2020;11:1446\u201356.","journal-title":"J Cancer"},{"key":"2413_CR32","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood.2019002600","volume":"134","author":"LK Hilton","year":"2019","unstructured":"Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 2019;134:1528\u201332.","journal-title":"Blood"},{"key":"2413_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13238-016-0316-z","volume":"7","author":"Q Fan","year":"2016","unstructured":"Fan Q, Meng X, Liang H, Zhang H, Liu X, Li L, et al. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma. Protein cell. 2016;7:899\u2013912.","journal-title":"Protein cell"},{"key":"2413_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s11658-020-00210-3","volume":"25","author":"N Sun","year":"2020","unstructured":"Sun N, Zhang L, Zhang C, Yuan Y. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt\/\u03b2-catenin signaling. Cell Mol Biol Lett. 2020;25:19.","journal-title":"Cell Mol Biol Lett"},{"key":"2413_CR35","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","volume":"20","author":"N Kerres","year":"2017","unstructured":"Kerres N, Steurer S, Schlager S, Bader G, Berger H, Caligiuri M, et al. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6. Cell Rep. 2017;20:2860\u201375.","journal-title":"Cell Rep"},{"key":"2413_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-020-2925-1","volume":"588","author":"M S\u0142abicki","year":"2020","unstructured":"S\u0142abicki M, Yoon H, Koeppel J, Nitsch L, Roy Burman SS, Di Genua C, et al. Small-molecule-induced polymerization triggers degradation of BCL6. Nature. 2020;588:164\u20138.","journal-title":"Nature"},{"key":"2413_CR37","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1172\/JCI85795","volume":"126","author":"MG Cardenas","year":"2016","unstructured":"Cardenas MG, Yu W, Beguelin W, Teater MR, Geng H, Goldstein RL, et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Investig. 2016;126:3351\u201362.","journal-title":"J Clin Investig"},{"key":"2413_CR38","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1158\/0008-5472.CAN-07-6866","volume":"68","author":"MD Hogarty","year":"2008","unstructured":"Hogarty MD, Norris MD, Davis K, Liu X, Evageliou NF, Hayes CS, et al. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res. 2008;68:9735\u201345.","journal-title":"Cancer Res"},{"key":"2413_CR39","first-page":"226","volume":"4","author":"H Bassiri","year":"2015","unstructured":"Bassiri H, Benavides A, Haber M, Gilmour SK, Norris MD, Hogarty MD. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma. Transl pediatrics. 2015;4:226\u201338.","journal-title":"Transl pediatrics"},{"key":"2413_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8530","volume":"6","author":"L Phan","year":"2015","unstructured":"Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, et al. The cell cycle regulator 14-3-3\u03c3 opposes and reverses cancer metabolic reprogramming. Nat Commun. 2015;6:7530.","journal-title":"Nat Commun"},{"key":"2413_CR41","doi-asserted-by":"publisher","first-page":"2000681","DOI":"10.1002\/advs.202000681","volume":"7","author":"HH Choi","year":"2020","unstructured":"Choi HH, Zou S, Wu JL, Wang H, Phan L, Li K, et al. EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis. Adv Sci. 2020;7:2000681.","journal-title":"Adv Sci"},{"key":"2413_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/thno.28992","volume":"9","author":"YL Zheng","year":"2019","unstructured":"Zheng YL, Li L, Jia YX, Zhang BZ, Li JC, Zhu YH, et al. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt\/mTOR Signaling Pathway. Theranostics. 2019;9:796\u2013810.","journal-title":"Theranostics"},{"key":"2413_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0680-1","volume":"16","author":"H Wang","year":"2017","unstructured":"Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol cancer. 2017;16:136.","journal-title":"Mol cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02413-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:02:47Z","timestamp":1758189767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02413-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":43,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["2413"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02413-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}